S. Pestkaand and A. Meager. Interferon standardization and designations. J. Interferon. Cytokine Res.
17(Suppl 1):S9–S14 (1997).
P. Jouet, F. Roudot-Thoraval, D. Dhumeaux, and J. M. Metreau. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le groupe Francais pour l’etude du traitement des hepatites chroniques NANB/C. Gastroenterology
S. Schenker, D. Cutler, J. Finch, C. H. Tamburro, M. Affrime, R. Sabo, and M. Bay. Activity and tolerance of a continuous subcutaneous infusion of interferon-alpha2b in patients with chronic hepatitis. C. J. Interferon. Cytokine Res.
V. Bocci, F. Carraro, A. Naldini, P. P. Cagol, E. M. Pasqual, C. Prevaldi, and D. Casara. Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases. Mol. Biother.
A. Bonettiand, and S. Kim. Pharmacokinetics of an extended-release human interferon alpha-2b formulation. Cancer Chemother. Pharmacol.
Y. Yoshikawa, Y. Komuta, T. Nishihara, Y. Itoh, H. Yoshikawa, and K. Takada. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats. J. Drug Target.
J. S. Patton, P. Trinchero, and R. M. Platz. Bioavailability of pulmonary delivered peptides and proteins: a-interferon, calcitonins and parathyroid hormones. J. Control. Release.
L. Paulesu, F. Corradeschi, C. Nicoletti, and V. Bocci. Oral administration of human recombinant interferon-a2 in rats. Int. J. Pharm.
C. K. Shimand, and S. R. Kim. Administration route dependent bioavailability of interferon-a and effect of bile salts on the nasal absorption. Drug Dev. Ind. Pharm.
S. Henry, D. V. McAllister, M. G. Allen, and M. R. Prausnitz. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci.
W. Lin, M. Cormier, A. Samiee, A. Griffin, B. Johnson, C. L. Teng, G. E. Hardee, and P. E. Daddona. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm. Res.
D. V. McAllister, M. G. Allen, and M. R . Prausnitz. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng.
D. P. Joshi, C. A., S. L. Chang, S. E. Mills, A. M. Smith, and A. K. Banga. Steady insulin infusion visa micropores through the stratum corneum in hairless arts. AAPS PharmSci.
A. Smith, D. Yang, H. Delcher, J. Eppstein, D. Williams, and S. Wilkes. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. Diabetes Technol. Ther.
A. M. Smith, J. A. Eppstein, H. K. Delcher, M. S. McRae, T. J. Woods, D. J. Williams, and M. R. Hatch. Transdermal insulin infusion through thermally created micropores in humans. Diabetes
A. M. Smith, T. J. Woods, D. J. Williams, H. K. Delcher, J. A. Eppstein, and M. S. McRae. Transdermal basal insulin delivery through micropores. Diabetes
J. Eppstein, M. R. Hatch, and D. Yang. Microporation of human skin for drug delivery and monitoring applications. US Patent 5885211 (1999).
J. Bramson, K. Dayball, C. Evelegh, Y. H. Wan, D. Page, and A. Smith. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther.
M. Al-Khalili, V. M. Meidan, and B. B. Michniak. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS PharmSci.
N. Sekkat, Y. N. Kalia, and R. H. Guy. Control of drug delivery across an impaired skin barrier by iontophoresis. In Proceedings of the 28th International Symposium on Controlled Release of Bioactive Materials and 4th Consumer & Diversified Products Conference, San Diego, CA, United States, June 23–27, 2001, pp. 1:185–186.
N. Sekkat, Y. N. Kalia, and R. H. Guy. Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates. Pharm. Res.
P. G. Green. Iontophoretic delivery of peptide drugs. J. Control. Release.
A. K. Banga. Electrically Assisted Transdermal and Topical Drug Delivery, Taylor & Francis, London, 1998.
A. V. Badkar, and A. K. Banga. Electrically enhanced transdermal delivery of a macromolecule. J. Pharm. Pharmacol.
S. L. Chang, A. M. Smith, S. E. Mills, D. P. Joshi, A. V. Badkar, and A. K. Banga. Transdermal delivery of human parathyroid hormone 1–34 by thermally created micropores and electrotransport. AAPS PharmSci.
N. G. Turner, L. Ferry, M. Price, C. Cullander, and R. H. Guy. Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm. Res.
V. Bocci, F. Corradeschi, A. Naldini, and E. Lencioni. Enteric absorption of human interferons a and b in the rat. International Journal of Pharmaceutics
O. Bohoslawec, P. W. Trown, and R. J. Wills. Pharmacokinetics and tissue distribution of recombinant human alpha A, D, A/D(Bgl), and I interferons and mouse alpha-interferon in mice. J. Interferon Res.
N. H. Greig, T. T. Soncrant, K. M. Wozniak, and S. I. Rapoport. Plasma and tissue pharmacokinetics of human interferon-alpha in the rat after its intravenous administration. J. Pharmacol. Exp. Ther.
G. M. Kavanagh, C. Oh, and K. Shams. BOTOX delivery by iontophoresis. Br. J. Dermatol.
S. Pacini, T. Punzi, M. Gulisano, F. Cecchi, S. Vannucchi, and M. Ruggiero. Transdermal delivery of heparin using pulsed current iontophoresis. Pharm. Res.
S. Pacini, T. Punzi, M. Gulisano, and M. Ruggiero. Pulsed current iontophoresis of hyaluronic acid in living rat skin. J. Dermatol. Sci.
A. K. Banga. New technologies to allow transdermal delivery of therapeutic proteins and small water soluble drugs. Am. J. Drug Deliv.